Skip to main content
Top
Published in: Addiction Science & Clinical Practice 1/2019

Open Access 01-12-2019 | Case Report

How to overcome political and legal barriers to the implementation of a drug consumption room: an application of the policy agenda framework to the Belgian situation

Authors: Pierre Smith, Louis Favril, Dominique Delhauteur, Freya Vander Laenen, Pablo Nicaise

Published in: Addiction Science & Clinical Practice | Issue 1/2019

Login to get access

Abstract

Background

For more than 30 years, drug consumption rooms (DCRs) have been implemented in Western countries. DCRs are supported by a large body of evidence about public safety and public health effectiveness. However, a political consensus has never been achieved in Belgium on amending the existing law that explicitly penalises the supply of a room for facilitating drug use. Despite this adverse legal and policy framework, a DCR opened in the city of Liège in 2018. In this case report, we applied the theoretical framework proposed by Shiffman and Smith for policy agenda setting, in order to describe and assess how political and legal barriers were overcome in the process of opening the DCR.

Case presentation

For some years, fieldworkers and some city policymakers argued for DCR implementation in Belgium, but without gaining the support of the national authorities, mainly for ideological reasons. In order to address this debate, a feasibility study of DCR implementation in Belgian cities was commissioned. At the national level, an institutional debate took place about the political responsibility for DCRs as a public health intervention, as health care is mainly a matter of regional policy. The lack of consensus led to a situation of political deadlock. Meanwhile, the publication of the study report and the context of local elections offered an opportunity for Liège authorities to reignite the local debate on DCRs. At the local level, law enforcement, care professionals, residents, users, and the press were all involved in the implementation process. Therefore, a local consensus was formed and despite the absence of any national legal change, the DCR opened 1 month before the local elections. It has been working without major medical or legal incident since then. Incidentally, the mayor of Liège was re-elected.

Conclusions

Although the lack of a legal framework may engender instability and affect longer-term effectiveness, the DCR implementation in Liège was successful and was based on a local consensus and effective communication rather than on an appropriate legal framework. The experience provides lessons for other cities that are considering opening a DCR despite an adverse legal and political context.
Literature
1.
go back to reference Schatz E, Nougier M. Drug consumption rooms: evidence and practice. London: International Drug Policy Consortium; 2012. Schatz E, Nougier M. Drug consumption rooms: evidence and practice. London: International Drug Policy Consortium; 2012.
2.
go back to reference Kimber J, Dolan K, van Beek I, Hedrich D, Zurhold H. Drug consumption facilities: an update since 2000. Drug Alcohol Rev. 2003;22(2):227–33.CrossRefPubMed Kimber J, Dolan K, van Beek I, Hedrich D, Zurhold H. Drug consumption facilities: an update since 2000. Drug Alcohol Rev. 2003;22(2):227–33.CrossRefPubMed
3.
go back to reference EMCDDA. Drug consumption rooms: an overview of provision and evidence. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2018. EMCDDA. Drug consumption rooms: an overview of provision and evidence. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2018.
4.
go back to reference Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet. 2005;366(9482):316–8.CrossRefPubMed Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet. 2005;366(9482):316–8.CrossRefPubMed
5.
go back to reference Milloy MJ, Wood E. Emerging role of supervised injecting facilities in human immunodeficiency virus prevention. Addiction. 2009;104(4):620–1.CrossRefPubMed Milloy MJ, Wood E. Emerging role of supervised injecting facilities in human immunodeficiency virus prevention. Addiction. 2009;104(4):620–1.CrossRefPubMed
6.
go back to reference Kennedy MC, Karamouzian M, Kerr T. Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review. Curr HIV/AIDS Rep. 2017;14(5):161–83.CrossRefPubMed Kennedy MC, Karamouzian M, Kerr T. Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review. Curr HIV/AIDS Rep. 2017;14(5):161–83.CrossRefPubMed
7.
go back to reference Potier C, Laprevote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48–68.CrossRefPubMed Potier C, Laprevote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48–68.CrossRefPubMed
8.
go back to reference EMCDDA. Drug-related infectious diseases in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2017. EMCDDA. Drug-related infectious diseases in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2017.
9.
go back to reference Hedrich D, Kerr T, Dubois-Arber F. Drug consumption facilities in Europe and beyond. In: Rhodes T, Hedrich D, editors. Harm reduction: evidence, impacts and challenges, EMCDDA Scientific Monograph Series No 10. Luxembourg: Publications Office of the European Union; 2010. p. 305–31. Hedrich D, Kerr T, Dubois-Arber F. Drug consumption facilities in Europe and beyond. In: Rhodes T, Hedrich D, editors. Harm reduction: evidence, impacts and challenges, EMCDDA Scientific Monograph Series No 10. Luxembourg: Publications Office of the European Union; 2010. p. 305–31.
10.
go back to reference Wood E, Tyndall M, Stoltz JA, Small W, Lloyd-Smith E, Zhang R, et al. Factors associated with syringe sharing among users of a medically supervised safer injecting facility. Am J Infect Dis. 2005;1(1):50–4.CrossRef Wood E, Tyndall M, Stoltz JA, Small W, Lloyd-Smith E, Zhang R, et al. Factors associated with syringe sharing among users of a medically supervised safer injecting facility. Am J Infect Dis. 2005;1(1):50–4.CrossRef
11.
go back to reference DeBeck K, Kerr T, Bird L, Zhang R, Marsh D, Tyndall M, et al. Injection drug use cessation and use of North America’s first medically supervised safer injecting facility. Drug Alcohol Depend. 2011;113(2–3):172–6.CrossRefPubMed DeBeck K, Kerr T, Bird L, Zhang R, Marsh D, Tyndall M, et al. Injection drug use cessation and use of North America’s first medically supervised safer injecting facility. Drug Alcohol Depend. 2011;113(2–3):172–6.CrossRefPubMed
12.
go back to reference Kimber J, Mattick RP, Kaldor J, van Beek I, Gilmour S, Rance JA. Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre. Drug Alcohol Rev. 2008;27(6):602–12.CrossRefPubMed Kimber J, Mattick RP, Kaldor J, van Beek I, Gilmour S, Rance JA. Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre. Drug Alcohol Rev. 2008;27(6):602–12.CrossRefPubMed
13.
go back to reference Toth EC, Tegner J, Lauridsen S, Kappel N. A cross-sectional national survey assessing self-reported drug intake behavior, contact with the primary sector and drug treatment among service users of Danish drug consumption rooms. Harm Reduct J. 2016;13(1):27.CrossRefPubMedPubMedCentral Toth EC, Tegner J, Lauridsen S, Kappel N. A cross-sectional national survey assessing self-reported drug intake behavior, contact with the primary sector and drug treatment among service users of Danish drug consumption rooms. Harm Reduct J. 2016;13(1):27.CrossRefPubMedPubMedCentral
14.
go back to reference Small W, Van Borek N, Fairbairn N, Wood E, Kerr T. Access to health and social services for IDU: the impact of a medically supervised injection facility. Drug Alcohol Rev. 2009;28(4):341–6.CrossRefPubMed Small W, Van Borek N, Fairbairn N, Wood E, Kerr T. Access to health and social services for IDU: the impact of a medically supervised injection facility. Drug Alcohol Rev. 2009;28(4):341–6.CrossRefPubMed
15.
go back to reference Bravo MJ, Royuela L, De la Fuente L, Brugal MT, Barrio G, Domingo-Salvany A. Use of supervised injection facilities and injection risk behaviours among young drug injectors. Addiction. 2009;104(4):614–9.CrossRefPubMed Bravo MJ, Royuela L, De la Fuente L, Brugal MT, Barrio G, Domingo-Salvany A. Use of supervised injection facilities and injection risk behaviours among young drug injectors. Addiction. 2009;104(4):614–9.CrossRefPubMed
16.
go back to reference Goodhew M, Salmon AM, Marel C, Mills KL, Jauncey M. Mental health among clients of the Sydney Medically Supervised Injecting Centre (MSIC). Harm Reduct J. 2016;13:29.CrossRefPubMedPubMedCentral Goodhew M, Salmon AM, Marel C, Mills KL, Jauncey M. Mental health among clients of the Sydney Medically Supervised Injecting Centre (MSIC). Harm Reduct J. 2016;13:29.CrossRefPubMedPubMedCentral
17.
go back to reference Wood E, Tyndall MW, Montaner JS, Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ. 2006;175(11):1399–404.CrossRefPubMedPubMedCentral Wood E, Tyndall MW, Montaner JS, Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ. 2006;175(11):1399–404.CrossRefPubMedPubMedCentral
18.
go back to reference Belackova V, Salmon AM. Overview of the international literature: supervised injecting facilities and drug consumption rooms. Sydney: Uniting Medically Supervised Injecting Centre; 2017. Belackova V, Salmon AM. Overview of the international literature: supervised injecting facilities and drug consumption rooms. Sydney: Uniting Medically Supervised Injecting Centre; 2017.
19.
go back to reference EMCDDA. EU Action Plan on Drugs 2017–2020, Official Journal, C215/21, Brussels, 5.07.207. 2017. EMCDDA. EU Action Plan on Drugs 2017–2020, Official Journal, C215/21, Brussels, 5.07.207. 2017.
20.
go back to reference INCB. INCB report 2016, nr. 718-719-720. 2016. INCB. INCB report 2016, nr. 718-719-720. 2016.
21.
go back to reference Kerr T, Stoltz JA, Tyndall M, Li K, Zhang R, Montaner J, et al. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study. BMJ. 2006;332(7535):220–2.CrossRefPubMedPubMedCentral Kerr T, Stoltz JA, Tyndall M, Li K, Zhang R, Montaner J, et al. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study. BMJ. 2006;332(7535):220–2.CrossRefPubMedPubMedCentral
22.
go back to reference Kerr T, Tyndall MW, Zhang R, Lai C, Montaner JSG, Wood E. Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility. Am J Public Health. 2007;97(7):1228–30.CrossRefPubMedPubMedCentral Kerr T, Tyndall MW, Zhang R, Lai C, Montaner JSG, Wood E. Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility. Am J Public Health. 2007;97(7):1228–30.CrossRefPubMedPubMedCentral
23.
go back to reference Lange BCL, Bach-Mortensen AM. A systematic review of stakeholder perceptions of supervised injection facilities. Drug Alcohol Depend. 2019;197:299–314.CrossRefPubMed Lange BCL, Bach-Mortensen AM. A systematic review of stakeholder perceptions of supervised injection facilities. Drug Alcohol Depend. 2019;197:299–314.CrossRefPubMed
24.
go back to reference Semaan S, Fleming P, Worrell C, Stolp H, Baack B, Miller M. Potential role of safer injection facilities in reducing HIV and hepatitis C infections and overdose mortality in the United States. Drug Alcohol Depend. 2011;118(2–3):100–10.CrossRefPubMed Semaan S, Fleming P, Worrell C, Stolp H, Baack B, Miller M. Potential role of safer injection facilities in reducing HIV and hepatitis C infections and overdose mortality in the United States. Drug Alcohol Depend. 2011;118(2–3):100–10.CrossRefPubMed
25.
go back to reference Kilmer B, Taylor J, Caulkins JP, Mueller PA, Ober AJ, Pardo B, et al. Considering heroin-assisted treatment and supervised drug consumption sites in the United States. Santa Monica: RAND Corporation; 2018.CrossRef Kilmer B, Taylor J, Caulkins JP, Mueller PA, Ober AJ, Pardo B, et al. Considering heroin-assisted treatment and supervised drug consumption sites in the United States. Santa Monica: RAND Corporation; 2018.CrossRef
26.
go back to reference Barry CL, Sherman SG, Stone E, Kennedy-Hendricks A, Niederdeppe J, Linden S, et al. Arguments supporting and opposing legalization of safe consumption sites in the U.S. Int J Drug Policy. 2019;63:18–22.CrossRefPubMed Barry CL, Sherman SG, Stone E, Kennedy-Hendricks A, Niederdeppe J, Linden S, et al. Arguments supporting and opposing legalization of safe consumption sites in the U.S. Int J Drug Policy. 2019;63:18–22.CrossRefPubMed
27.
go back to reference Gostin LO, Hodge JG Jr, Gulinson CL. Supervised injection facilities: legal and policy reforms. JAMA. 2019;321:745–6.CrossRefPubMed Gostin LO, Hodge JG Jr, Gulinson CL. Supervised injection facilities: legal and policy reforms. JAMA. 2019;321:745–6.CrossRefPubMed
28.
go back to reference ACMD. Reducing opioid-related deaths in the UK. London: Advisory Council on the Misuse of Drugs; 2016. ACMD. Reducing opioid-related deaths in the UK. London: Advisory Council on the Misuse of Drugs; 2016.
29.
go back to reference Lloyd C, Hunt N. Drug consumption rooms: an overdue extension to harm reduction policy in the UK? Int J Drug Policy. 2007;18(1):5–9.CrossRefPubMed Lloyd C, Hunt N. Drug consumption rooms: an overdue extension to harm reduction policy in the UK? Int J Drug Policy. 2007;18(1):5–9.CrossRefPubMed
30.
go back to reference Lloyd N, Stover H, Zurhold H, Hunt N. Similar problems, divergent responses: drug consumption room policies in the UK and Germany. J Subst Use. 2016;22:66–70.CrossRef Lloyd N, Stover H, Zurhold H, Hunt N. Similar problems, divergent responses: drug consumption room policies in the UK and Germany. J Subst Use. 2016;22:66–70.CrossRef
31.
go back to reference Vander Laenen F, Nicaise P, Decorte T, De Maeyer J, De Ruyver B, Smith P, et al. Feasibility study on drug consumption rooms in Belgium. Brussels: Belgian Science Policy Office (BELSPO); 2018. Vander Laenen F, Nicaise P, Decorte T, De Maeyer J, De Ruyver B, Smith P, et al. Feasibility study on drug consumption rooms in Belgium. Brussels: Belgian Science Policy Office (BELSPO); 2018.
32.
go back to reference Hunt N. Guidance on standards for the establishment and operation of drug consumption rooms in the UK. York: Joseph Rowntree Foundation; 2008. Hunt N. Guidance on standards for the establishment and operation of drug consumption rooms in the UK. York: Joseph Rowntree Foundation; 2008.
33.
go back to reference Schultz H. Die Rechtsstellung der Fixerräume. Schweizerische Zeitschrift für Strafrecht, Bd. 106, Heft 3, Bern. [Gutachten gem. Vertrag vom 14./18.November 1988 der Eidgenössischen Betäubungsmittelkommission]. Bundesamt für Gesundheitswesen. 1989. Schultz H. Die Rechtsstellung der Fixerräume. Schweizerische Zeitschrift für Strafrecht, Bd. 106, Heft 3, Bern. [Gutachten gem. Vertrag vom 14./18.November 1988 der Eidgenössischen Betäubungsmittelkommission]. Bundesamt für Gesundheitswesen. 1989.
34.
go back to reference Körner HH. Strafrechtliches Gutachten zur Zulässigkeit von Gesundheitsräumen für den hygienischen und stressfreien Konsum von Opiatabhängigen. Frankfurt am Main. 1993. Körner HH. Strafrechtliches Gutachten zur Zulässigkeit von Gesundheitsräumen für den hygienischen und stressfreien Konsum von Opiatabhängigen. Frankfurt am Main. 1993.
35.
go back to reference La loi de modernisation de notre système de santé du 26 janvier 2016. Ministère des Affaires sociales, de la Santé et des Droits des femmes. 2016. La loi de modernisation de notre système de santé du 26 janvier 2016. Ministère des Affaires sociales, de la Santé et des Droits des femmes. 2016.
36.
go back to reference Dooling K, Rachlis M. Vancouver’s supervised injection facility challenges Canada’s drug laws. Cana Med Assoc J. 2010;182:1440–4.CrossRef Dooling K, Rachlis M. Vancouver’s supervised injection facility challenges Canada’s drug laws. Cana Med Assoc J. 2010;182:1440–4.CrossRef
37.
go back to reference Barendregt C, Rodenburg G. Een gebruiksruimte in Antwerpen: wenselijk en haalbaar?. Amsterdam: Instituut voor Onderzoek naar Leefwijzen & Verslaving; 2004. Barendregt C, Rodenburg G. Een gebruiksruimte in Antwerpen: wenselijk en haalbaar?. Amsterdam: Instituut voor Onderzoek naar Leefwijzen & Verslaving; 2004.
38.
go back to reference Favril L, Vander Laenen F, Decorte T. Schadebeperkende maatregelen voor de stad Gent. Een onderzoek naar de lokale noden en prioriteiten. Antwerpen: Maklu; 2015. Favril L, Vander Laenen F, Decorte T. Schadebeperkende maatregelen voor de stad Gent. Een onderzoek naar de lokale noden en prioriteiten. Antwerpen: Maklu; 2015.
39.
go back to reference Demaret I, Herné P, Lemaître A, Ansseau M. Feasibility assessment of heroin-assisted treatment in Liège. Acta Psychiatr Belg. 2011;111(1):3–8. Demaret I, Herné P, Lemaître A, Ansseau M. Feasibility assessment of heroin-assisted treatment in Liège. Acta Psychiatr Belg. 2011;111(1):3–8.
40.
go back to reference Aertsen P, Dheedene P, Ruyters T, Verstuyf G, Windelinckx T. Gebruiksruimtes: visie vanuit het gezondheidsperspectief. Definitie, doelstellingen, modaliteiten. Brussel: Vereniging voor Alcohol- en andere Drugproblemen (VAD). 2014. Aertsen P, Dheedene P, Ruyters T, Verstuyf G, Windelinckx T. Gebruiksruimtes: visie vanuit het gezondheidsperspectief. Definitie, doelstellingen, modaliteiten. Brussel: Vereniging voor Alcohol- en andere Drugproblemen (VAD). 2014.
41.
go back to reference Shiffman J, Smith S. Generation of political priority for global health initiatives: a framework and case study of maternal mortality. Lancet. 2007;370(9595):1370–9.CrossRefPubMed Shiffman J, Smith S. Generation of political priority for global health initiatives: a framework and case study of maternal mortality. Lancet. 2007;370(9595):1370–9.CrossRefPubMed
42.
go back to reference Scheufele DA. Agenda-setting, priming, and framing revisited: another look at cognitive effects of political communication. Mass Commun Soc. 2000;3(2–3):297–316.CrossRef Scheufele DA. Agenda-setting, priming, and framing revisited: another look at cognitive effects of political communication. Mass Commun Soc. 2000;3(2–3):297–316.CrossRef
43.
go back to reference Finnemore M, Sikkink K. Taking stock: the constructivist research program in international relations and comparative politics. Annu Rev Polit Sci. 2001;4:391–416.CrossRef Finnemore M, Sikkink K. Taking stock: the constructivist research program in international relations and comparative politics. Annu Rev Polit Sci. 2001;4:391–416.CrossRef
44.
go back to reference Shiffman J. Issue attention in global health: the case of newborn survival. Lancet. 2010;375(9730):2045–9.CrossRefPubMed Shiffman J. Issue attention in global health: the case of newborn survival. Lancet. 2010;375(9730):2045–9.CrossRefPubMed
46.
go back to reference Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377(9775):1438–47.CrossRefPubMed Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377(9775):1438–47.CrossRefPubMed
47.
go back to reference Geneau R, Stuckler D, Stachenko S, McKee M, Ebrahim S, Basu S, et al. Raising the priority of preventing chronic diseases: a political process. Lancet. 2010;376(9753):1689–98.CrossRefPubMed Geneau R, Stuckler D, Stachenko S, McKee M, Ebrahim S, Basu S, et al. Raising the priority of preventing chronic diseases: a political process. Lancet. 2010;376(9753):1689–98.CrossRefPubMed
48.
go back to reference Wallace K, Roberts B. An exploration of the alcohol policy environment in post-conflict countries. Alcohol Alcohol. 2014;49(3):356–62.CrossRefPubMed Wallace K, Roberts B. An exploration of the alcohol policy environment in post-conflict countries. Alcohol Alcohol. 2014;49(3):356–62.CrossRefPubMed
49.
go back to reference Buse K, Mays N, Walt G. Making health policy. 2nd ed. New York: McGraw-Hill Education; 2012. Buse K, Mays N, Walt G. Making health policy. 2nd ed. New York: McGraw-Hill Education; 2012.
50.
go back to reference Demoulin B. Histoire de Liège: Une cité, une capitale, une métropole. Marot. 2017;368 p. Demoulin B. Histoire de Liège: Une cité, une capitale, une métropole. Marot. 2017;368 p.
51.
go back to reference Demoulin B, Kupper J-L. Histoire de la principauté de Liège: de l’an mille à la Révolution Privat. 2002; p. 282. Demoulin B, Kupper J-L. Histoire de la principauté de Liège: de l’an mille à la Révolution Privat. 2002; p. 282.
52.
go back to reference Leboutte R, Puissant J, Scuto D. Un siècle d’histoire industrielle (1873–1973): Belgique, Luxembourg, Pays-Bas, industrialisation et sociétés. Paris: Éditions SEDES; 1998. Leboutte R, Puissant J, Scuto D. Un siècle d’histoire industrielle (1873–1973): Belgique, Luxembourg, Pays-Bas, industrialisation et sociétés. Paris: Éditions SEDES; 1998.
53.
go back to reference White G. Crime and the decline of manufacturing, 1970–1990. Just Q. 1999;16(1):81–97.CrossRef White G. Crime and the decline of manufacturing, 1970–1990. Just Q. 1999;16(1):81–97.CrossRef
54.
go back to reference Lemaire I, Devillers S, Guillaume J-C. Immersion dans le Liège des toxicomanes. Brussels: La Libre Belgique; 2018. Lemaire I, Devillers S, Guillaume J-C. Immersion dans le Liège des toxicomanes. Brussels: La Libre Belgique; 2018.
55.
go back to reference Stévenot C, Hogge M. L’usage de drogues en Wallonie et à Bruxelles. Brussels: EUROTOX; 2017. Stévenot C, Hogge M. L’usage de drogues en Wallonie et à Bruxelles. Brussels: EUROTOX; 2017.
56.
go back to reference Liège. Réflexion relative à la mise en place d’une salle de consommation à moindre risque à Liège. Concertation intersectorielle finalisée - Juin 2018. Liège Plan de prévention. 2018. Liège. Réflexion relative à la mise en place d’une salle de consommation à moindre risque à Liège. Concertation intersectorielle finalisée - Juin 2018. Liège Plan de prévention. 2018.
57.
go back to reference Demaret I. Projet TADAM, rapport final, section IV. Recommendations: pour un centre de traitement par diacétylmorphine. Liège: Université de Liège; 2013. Demaret I. Projet TADAM, rapport final, section IV. Recommendations: pour un centre de traitement par diacétylmorphine. Liège: Université de Liège; 2013.
58.
go back to reference Demaret I, Quertemont E, Litran G, Magoga C, Deblire C, Dubois N, et al. Efficacy of heroin-assisted treatment in belgium: a randomised controlled trial. Eur Addict Res. 2015;21(4):179–87.CrossRefPubMed Demaret I, Quertemont E, Litran G, Magoga C, Deblire C, Dubois N, et al. Efficacy of heroin-assisted treatment in belgium: a randomised controlled trial. Eur Addict Res. 2015;21(4):179–87.CrossRefPubMed
59.
go back to reference Van Caillie D. Projet TADAM, Rapport Final, Section III, Chapitre F. Analyse socioéconomique. Analyse coûts-bénéfices comparée des traitements DAM et méthadone: l’expérience TADAM (2011–2012). Université de Liège Centre d’Etude de la Performance des Entreprises. 2013. Van Caillie D. Projet TADAM, Rapport Final, Section III, Chapitre F. Analyse socioéconomique. Analyse coûts-bénéfices comparée des traitements DAM et méthadone: l’expérience TADAM (2011–2012). Université de Liège Centre d’Etude de la Performance des Entreprises. 2013.
60.
go back to reference Demeyer W, Lalieux K, Ozen O, Massin E. Proposition de Loi complétant la loi du 24 février 1921 concernant le trafic des substances vénéneuses, soporifiques, stupéfiantes, sychotropes, désinfectantes ou antiseptiques et des substances pouvant servir à la fabrication illicite de substances stupéfiantes et psychotropes, visant à la reconnaissance légale du traitement assisté par diacétylmorphine Chambre des Représentants de Belgique - Session extraordinaire 16 septembre 2014. 2014. Demeyer W, Lalieux K, Ozen O, Massin E. Proposition de Loi complétant la loi du 24 février 1921 concernant le trafic des substances vénéneuses, soporifiques, stupéfiantes, sychotropes, désinfectantes ou antiseptiques et des substances pouvant servir à la fabrication illicite de substances stupéfiantes et psychotropes, visant à la reconnaissance légale du traitement assisté par diacétylmorphine Chambre des Représentants de Belgique - Session extraordinaire 16 septembre 2014. 2014.
61.
go back to reference CGPD. Salles de consommation à moindres risques. Cellule Générale de Politique Drogues. 2016. CGPD. Salles de consommation à moindres risques. Cellule Générale de Politique Drogues. 2016.
62.
go back to reference Dubois F. Drogue: ouvrir des “salles de shoot” en Belgique? C’est possible, conclut une étude. Brussels: RTBF—Radio-Télévision belge de la Communauté française; 2018. Dubois F. Drogue: ouvrir des “salles de shoot” en Belgique? C’est possible, conclut une étude. Brussels: RTBF—Radio-Télévision belge de la Communauté française; 2018.
63.
go back to reference Dubois F. Liège: les riverains découvrent la salle de consommation de drogue à moindre risque. Brussels: RTBF—Radio-Télévision belge de la Communauté française; 2018. Dubois F. Liège: les riverains découvrent la salle de consommation de drogue à moindre risque. Brussels: RTBF—Radio-Télévision belge de la Communauté française; 2018.
64.
go back to reference Belga. Liège: Le collège communal favorable à l’ouverture d’une salle de consommation pour toxicomanes. La Libre Belgique. 2018. Belga. Liège: Le collège communal favorable à l’ouverture d’une salle de consommation pour toxicomanes. La Libre Belgique. 2018.
65.
go back to reference Swenden W, Brans M, De Winter L. The politics of Belgium: Institutions and policy under bipolar and centrifugal federalism. West Eur Polit. 2006;29(5):863–73.CrossRef Swenden W, Brans M, De Winter L. The politics of Belgium: Institutions and policy under bipolar and centrifugal federalism. West Eur Polit. 2006;29(5):863–73.CrossRef
66.
go back to reference Varone F, Jacob S, De Winter L. Polity, politics and policy evaluation in Belgium. SAGE Journals. 2005;11(3):253–73. Varone F, Jacob S, De Winter L. Polity, politics and policy evaluation in Belgium. SAGE Journals. 2005;11(3):253–73.
67.
go back to reference Loughlin P. Subnational democracy in the European Union: challenges and opportunities. Oxford: Oxford University Press; 2001. Loughlin P. Subnational democracy in the European Union: challenges and opportunities. Oxford: Oxford University Press; 2001.
68.
go back to reference Gouvernement-Fédéral. Chambre des représentants de Belgique - Déclaration du Gouvernement Fédéral - 14 octobre 2014. 2014. Gouvernement-Fédéral. Chambre des représentants de Belgique - Déclaration du Gouvernement Fédéral - 14 octobre 2014. 2014.
69.
go back to reference FEDITO BXL. Politique Drogues & Plan Drogues en Région de Bruxelles-Capitale. Fédération bruxelloise francophone des institutions pour toxicomanes - FEDITO BXL asbl. 2015. FEDITO BXL. Politique Drogues & Plan Drogues en Région de Bruxelles-Capitale. Fédération bruxelloise francophone des institutions pour toxicomanes - FEDITO BXL asbl. 2015.
70.
go back to reference Béduwé C, Van Huyck C, Noël L. Plan Bruxellois de Réduction des Risques liés à l’usage de drogues. Bruxelles: Modus Vivendi ASBL, Forum Belge pour la Prévention et la Sécurité urbaine; 2014. Béduwé C, Van Huyck C, Noël L. Plan Bruxellois de Réduction des Risques liés à l’usage de drogues. Bruxelles: Modus Vivendi ASBL, Forum Belge pour la Prévention et la Sécurité urbaine; 2014.
71.
go back to reference Vander Laenen F, Favril L. Druggebruiksruimtes nog niet voor morgen. Sociaal.Net: Controversieel ondanks positieve onderzoeksresultaten; 2018. Vander Laenen F, Favril L. Druggebruiksruimtes nog niet voor morgen. Sociaal.Net: Controversieel ondanks positieve onderzoeksresultaten; 2018.
72.
go back to reference Liège. « Task force drogue » Ville de Liège: Ville pilote en matière de gestion de la problématique des drogues. « Task force drogue » . 2003. Liège. « Task force drogue » Ville de Liège: Ville pilote en matière de gestion de la problématique des drogues. « Task force drogue » . 2003.
73.
go back to reference Neuforge S. Plan stratégique liégeois en matière de drogues. Bilan décembre 2002—août 2007. Ville de Liège 2007. Neuforge S. Plan stratégique liégeois en matière de drogues. Bilan décembre 2002—août 2007. Ville de Liège 2007.
74.
go back to reference Parlement Wallon. Rapport d’activités. Session ordinaire 2017-2018, 5ème session de la 10e législature. 2018. Parlement Wallon. Rapport d’activités. Session ordinaire 2017-2018, 5ème session de la 10e législature. 2018.
75.
go back to reference Parlement Wallon. Compte rendu intégral - séance plénière - mercredi 28 février 2018. 2018. Parlement Wallon. Compte rendu intégral - séance plénière - mercredi 28 février 2018. 2018.
76.
go back to reference Maron A, Genot Z. Proposition d’ordonnance relative à la réduction des risques liés aux usages de drogues. Bruxelles: Assemblée réunie de la Commission Communautaire Commune (COCOM); 2018. Maron A, Genot Z. Proposition d’ordonnance relative à la réduction des risques liés aux usages de drogues. Bruxelles: Assemblée réunie de la Commission Communautaire Commune (COCOM); 2018.
77.
go back to reference CPG. Collège des procureurs généraux - Salles de consommation de drogue - salles d’injection. Ministère Public. 2018. CPG. Collège des procureurs généraux - Salles de consommation de drogue - salles d’injection. Ministère Public. 2018.
78.
go back to reference Jauffret-Roustide M, Pedrono G, Beltzer N. Supervised consumption rooms: the French Paradox. Int J Drug Policy. 2013;24(6):628–30.CrossRefPubMed Jauffret-Roustide M, Pedrono G, Beltzer N. Supervised consumption rooms: the French Paradox. Int J Drug Policy. 2013;24(6):628–30.CrossRefPubMed
79.
go back to reference Independent Drugs Commission for Brighton and Hove. Report and Recommendations. Safe in the city. Brighton: Independent Drugs Commission for Brighton and Hove; 2013. Independent Drugs Commission for Brighton and Hove. Report and Recommendations. Safe in the city. Brighton: Independent Drugs Commission for Brighton and Hove; 2013.
80.
go back to reference Sérès A. Salle de shoot à Paris: une association porte plainte. Paris: Le Figaro; 2013. Sérès A. Salle de shoot à Paris: une association porte plainte. Paris: Le Figaro; 2013.
81.
go back to reference Jauffret-Roustide M, Cailbault I. Drug consumption rooms: comparing times, spaces and actors in issues of social acceptability in French public debate. Int J Drug Policy. 2018;56:208–17.CrossRefPubMed Jauffret-Roustide M, Cailbault I. Drug consumption rooms: comparing times, spaces and actors in issues of social acceptability in French public debate. Int J Drug Policy. 2018;56:208–17.CrossRefPubMed
82.
go back to reference Centre P. Guidance on community consultation and engagement related to implementation of supervised consumption service. Vancouver: The Dr Peter AIDS Foundation; 2017. Centre P. Guidance on community consultation and engagement related to implementation of supervised consumption service. Vancouver: The Dr Peter AIDS Foundation; 2017.
83.
go back to reference Woods S. Drug consumption rooms in Europe: organisational overview. Amsterdam: European Harm Reduction Network; 2014. Woods S. Drug consumption rooms in Europe: organisational overview. Amsterdam: European Harm Reduction Network; 2014.
84.
go back to reference Havinga P, Van der Poel A. Gebruiksruimten in Nederland: update van de handreiking bij organisatie en inrichting. Utrecht: Trimbos Instituut; 2011. Havinga P, Van der Poel A. Gebruiksruimten in Nederland: update van de handreiking bij organisatie en inrichting. Utrecht: Trimbos Instituut; 2011.
87.
go back to reference De Ruyver B, Vander Laenen F, Eelen S. The long road to an integral and integrated policy in Belgium. In: Muscat, R, Pike, B, members of the Coherent Policy Expert Group (eds). Reflections on the concept of coherency for a policy on psychoactive substances and beyond (33–42) Council of Europe Publishing, Strasbourg. 2012. De Ruyver B, Vander Laenen F, Eelen S. The long road to an integral and integrated policy in Belgium. In: Muscat, R, Pike, B, members of the Coherent Policy Expert Group (eds). Reflections on the concept of coherency for a policy on psychoactive substances and beyond (33–42) Council of Europe Publishing, Strasbourg. 2012.
88.
go back to reference Vander Laenen F, Vander Plasschen W, Smet V, De Maeyer J, Buckinx M, Van Audenhove S, et al. Analysis and optimization of substitution treatment in Belgium. Gent: Academia Press; 2013. p. 210. Vander Laenen F, Vander Plasschen W, Smet V, De Maeyer J, Buckinx M, Van Audenhove S, et al. Analysis and optimization of substitution treatment in Belgium. Gent: Academia Press; 2013. p. 210.
89.
go back to reference Goldwicht M. 20 ans d’échange de seringues en Belgique francophone. Modus Vivendi ASBL. p. 63. 2016. Goldwicht M. 20 ans d’échange de seringues en Belgique francophone. Modus Vivendi ASBL. p. 63. 2016.
90.
go back to reference CGPD. Rapport Annuel 2017. Cellule Générale de Politique Drogues. 2017. CGPD. Rapport Annuel 2017. Cellule Générale de Politique Drogues. 2017.
91.
go back to reference El Massaoudi S. Salles de shoot: “Un vrai réseau va bientôt se développer à Bruxelles”. La DH. 2019. El Massaoudi S. Salles de shoot: “Un vrai réseau va bientôt se développer à Bruxelles”. La DH. 2019.
92.
go back to reference Hovine A. Pourquoi l’installation de “salles de shoot” demeure problématique. Brussels: La Libre belgique; 2019. Hovine A. Pourquoi l’installation de “salles de shoot” demeure problématique. Brussels: La Libre belgique; 2019.
93.
go back to reference Rédaction. Bientôt une “salle de shoot” à Charleroi? 7 sur 7. 2019. Rédaction. Bientôt une “salle de shoot” à Charleroi? 7 sur 7. 2019.
94.
go back to reference Uyttendaele J, du Bus de Warnaffe A, Maingain F. Proposition de décret modifiant le « Décret relatif à l’offre de services ambulatoires dans les domaines de l’action sociale, de la famille et de la santé » afin d’autoriser la création de salles de consommation à moindre risque. Parlement francophone bruxellois (Assemblée de la Commission communautaire française) 8 mars 2019. 2019. Uyttendaele J, du Bus de Warnaffe A, Maingain F. Proposition de décret modifiant le « Décret relatif à l’offre de services ambulatoires dans les domaines de l’action sociale, de la famille et de la santé » afin d’autoriser la création de salles de consommation à moindre risque. Parlement francophone bruxellois (Assemblée de la Commission communautaire française) 8 mars 2019. 2019.
Metadata
Title
How to overcome political and legal barriers to the implementation of a drug consumption room: an application of the policy agenda framework to the Belgian situation
Authors
Pierre Smith
Louis Favril
Dominique Delhauteur
Freya Vander Laenen
Pablo Nicaise
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Addiction Science & Clinical Practice / Issue 1/2019
Electronic ISSN: 1940-0640
DOI
https://doi.org/10.1186/s13722-019-0169-x

Other articles of this Issue 1/2019

Addiction Science & Clinical Practice 1/2019 Go to the issue